The SWENOTECA ABC-study
- Mar 25, 2015
- 1 min read
The SWENOTECA now starts inclusion in the ABC-study. This is a randomized phase III study in stage I seminomatous testicular cancer. Patients with one or two risk factors (stromal invasion of the rete testis and/or tumor size over 4 cm) will be randomized between one course of adjuvant carboplatin (AUC7) or one course of standard BEP.
Comments